12C (AdaPTinsight) Affected component: AdaPTinsight software Product Usage: 12C is used with...
FDA Device Recall #Z-2109-2018 — Class II — October 28, 2016
Recall Summary
| Recall Number | Z-2109-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 28, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ion Beam Applications S.A. |
| Location | Louvain La Neuve, N/A |
| Product Type | Devices |
| Quantity | 5 units (12C) |
Product Description
12C (AdaPTinsight) Affected component: AdaPTinsight software Product Usage: 12C is used with a charged particle or photon radiation therapy system for localization of the patient position with respect to the therapy equipment and to provide correction feedback to the radiation therapy system.
Reason for Recall
IBA is initiating this recall to address an issue identified with AdaPTinsight software and to reduce risk related to this problem.
Distribution Pattern
Worldwide Distribution - US Nationwide in the states of LA, TX, Italy, Sweden and France. Each country's National Competent Authorities were notified of the firm's Field Safety Notice.
Lot / Code Information
Affected units: SAT.123, SAT.126, PAT.115, SAT.122 and SBF.101
Other Recalls from Ion Beam Applications S.A.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1497-2026 | Class II | IBA Proton Therapy System - PROTEUS 235 | Feb 3, 2026 |
| Z-2693-2024 | Class II | IBA Proton Therapy System - PROTEUS 235- Design... | Jul 10, 2024 |
| Z-3089-2024 | Class II | IBA Proton Therapy System - PROTEUS 235 Proteus... | Jul 8, 2024 |
| Z-1945-2024 | Class II | IBA Proton Therapy System - PROTEUS 235 - Desig... | May 10, 2024 |
| Z-1603-2024 | Class II | IBA Proton Therapy System - PROTEUS 235, PTS-10... | Mar 4, 2024 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.